(Q31151651)

29 June 2017

1 reference

title

Devic's neuromyelitis optica: a critical review (English)

1 reference

29 June 2017

1 reference

Marco Aurélio Lana-Peixoto

series ordinal

1

1 reference

29 June 2017

publication date

1 March 2008

1 reference

Arquivos de Neuro-Psiquiatria

29 June 2017

published in

1 reference

29 June 2017

volume

66

1 reference

29 June 2017

issue

1

1 reference

29 June 2017

page(s)

120-138

1 reference

The clinical course of neuromyelitis optica (Devic's syndrome).

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Brain abnormalities in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Devic's neuromyelitis optica: a clinicopathological study of 8 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Clinical, CSF, and MRI findings in Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Revised diagnostic criteria for neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Multiple sclerosis in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

The pattern of neurological illness in tropical Africa. Experience at Ibadan, Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Demyelinating disorder of the central nervous system occurring in black South Africans

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Multiple sclerosis amongst Chinese in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Nationwide survey of multiple sclerosis in Japan Clinical analysis of 1,084 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Epidemiology of multiple sclerosis in Arabs in Kuwait: a comparative study between Kuwaitis and Palestinians

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Natural history of the visual impairment of relapsing neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Is multiple sclerosis in Brazil and asia alike?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Optic neuromyelitis syndrome in Brazilian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Devic's neuromyelitis optica in an infant case

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Neuromyelitis optica in the old age: a clinico-pathological contribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Devic type multiple sclerosis in an 81 year old woman

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Neuromyelitis optica in a mother and daughter

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Devic disease in a child with primary Sjögren syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Three women with lupus transverse myelitis: case reports and differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Neuromyelitis optica with clinical and histopathological involvement of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

The molecular basis of water transport in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Anchoring of aquaporin-4 in brain: molecular mechanisms and implications for the physiology and pathophysiology of water transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Aquaporin-4, homeostasis, and neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Immunogold evidence suggests that coupling of K+ siphoning and water transport in rat retinal Müller cells is mediated by a coenrichment of Kir4.1 and AQP4 in specific membrane domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Aquaporins and brain edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Neuromyelitis optica: new findings on pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Comparison of the clinical courses of the opticospinal and conventional forms of multiple sclerosis in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Recurrent optic neuromyelitis with endocrinopathies: a new syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Devic's neuromyelitis optica: study of nine cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Neuromyelitis optica with hypothalamic involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Neuromyelitis optica: changing concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Neuromyelitis optica (Devic disease)_following varicella infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Devic's neuromyelitis optica and HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Acute necrotic myelopathy with pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Neuromyelitis optica (Devic's syndrome) and pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Neuromyelitis optica (Devic's disease) in a patient with syphilis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Pure optic-spinal form of multiple sclerosis in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Anti-aquaporin 4 antibody in Japanese multiple sclerosis: the presence of optic spinal multiple sclerosis without long spinal cord lesions and anti-aquaporin 4 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

The natural history of recurrent optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Fulminant Devic disease successfully treated by lymphocytapheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperIgEaemic myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

An open label study of the effects of rituximab in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Western vs optic-spinal MS: two diseases, one treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Relapsing neuromyelitis optica responsive to glatiramer acetate treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Sustained improvement of a girl affected with Devic's disease over 2 years of mycophenolate mofetil treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

NEUROMYELITIS OPTICA (DEVIC'S DISEASE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

Neuromyelitis Optica in Patients With Myasthenia Gravis Who Underwent Thymectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000100034

10.1590/S0004-282X2008000100034

21 January 2018

Identifiers

DOI

1 reference

29 June 2017

1 reference